Who
Seana Carson
EVP, General Counsel
Company insider
Files Form 4 as: EVP, General Counsel, Bausch Health Companies.
In numbers
- Trades disclosed
- 66
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $548K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 May 2022
- Last trade
- 3 Mar 2026
- Last filed
- 3 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Mar 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $26K4,420 at $5.77 | filing |
| 3 Mar 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $26K4,420 at $5.77 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $40K6,856 at $5.78 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $101K16,973 at $5.95 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code J | $821K137,922 at $5.95 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $40K6,856 at $5.78 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $101K16,973 at $5.95 | filing |
| 2 Mar 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code J | $821K137,922 at $5.95 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $156K26,326 at $5.93 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $156K26,326 at $5.93 | filing |
| 27 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $50K8,388 at $5.95 | filing |
| 27 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $50K8,388 at $5.95 | filing |
| 26 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $195K32,211 at $6.04 | filing |
| 26 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $195K32,211 at $6.04 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —212,350 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —212,350 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —137,922 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —137,922 at $0.00 | filing |
| 8 Sep 2025filed 8 Sep 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Sold | $98K13,370 at $7.31 | filing |
| 5 Sep 2025filed 8 Sep 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code F | $377K51,337 at $7.35 | filing |
News
Contrasting Ocular Therapeutix (NASDAQ:OCUL) and Bausch Health Cos (NYSE:BHC)BHC · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Seana Carson; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.